##gff-version 3
##sequence-region P10636 1 758
P10636	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1512244;Dbxref=PMID:1512244	
P10636	UniProtKB	Chain	2	758	.	.	.	ID=PRO_0000072739;Note=Microtubule-associated protein tau	
P10636	UniProtKB	Repeat	561	591	.	.	.	Note=Tau/MAP 1;Ontology_term=ECO:0000255,ECO:0000305;evidence=ECO:0000255|PROSITE-ProRule:PRU00824,ECO:0000305|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Repeat	592	622	.	.	.	Note=Tau/MAP 2;Ontology_term=ECO:0000255,ECO:0000305;evidence=ECO:0000255|PROSITE-ProRule:PRU00824,ECO:0000305|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Repeat	623	653	.	.	.	Note=Tau/MAP 3;Ontology_term=ECO:0000255,ECO:0000305;evidence=ECO:0000255|PROSITE-ProRule:PRU00824,ECO:0000305|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Repeat	654	685	.	.	.	Note=Tau/MAP 4;Ontology_term=ECO:0000255,ECO:0000305;evidence=ECO:0000255|PROSITE-ProRule:PRU00824,ECO:0000305|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Region	561	685	.	.	.	Note=Microtubule-binding domain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Site	24	24	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	44	44	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	67	67	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	381	381	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	391	391	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	392	392	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	394	394	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	465	465	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	497	497	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	507	507	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	541	541	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	557	557	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	571	571	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	574	574	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	584	584	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	591	591	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	607	607	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	611	611	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	615	615	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	628	628	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	634	634	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	638	638	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	648	648	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	657	657	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	660	660	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	687	687	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	692	692	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	700	700	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	702	702	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	712	712	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Site	755	755	.	.	.	Note=Not glycated;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1512244;Dbxref=PMID:1512244	
P10636	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphotyrosine%3B by FYN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14999081;Dbxref=PMID:14999081	
P10636	UniProtKB	Modified residue	29	29	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P19332	
P10636	UniProtKB	Modified residue	61	61	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P19332	
P10636	UniProtKB	Modified residue	69	69	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	71	71	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P19332	
P10636	UniProtKB	Modified residue	111	111	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	214	214	.	.	.	Note=Phosphoserine%3B by SGK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16982696;Dbxref=PMID:16982696	
P10636	UniProtKB	Modified residue	396	396	.	.	.	Note=Phosphoserine%3B in PHF-tau;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1899488;Dbxref=PMID:1899488	
P10636	UniProtKB	Modified residue	470	470	.	.	.	Note=Phosphothreonine%3B by PDPK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9614189;Dbxref=PMID:9614189	
P10636	UniProtKB	Modified residue	472	472	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	480	480	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	480	480	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	484	484	.	.	.	Note=Deamidated asparagine%3B in tau and PHF-tau%3B partial;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1512244;Dbxref=PMID:1512244	
P10636	UniProtKB	Modified residue	486	486	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	492	492	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	498	498	.	.	.	Note=Phosphothreonine%3B by PDPK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15546861;Dbxref=PMID:15546861	
P10636	UniProtKB	Modified residue	502	502	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	508	508	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	512	512	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	514	514	.	.	.	Note=Phosphotyrosine%3B by TTBK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16923168;Dbxref=PMID:16923168	
P10636	UniProtKB	Modified residue	515	515	.	.	.	Note=Phosphoserine%3B by PDPK1 and TTBK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16923168;Dbxref=PMID:16923168	
P10636	UniProtKB	Modified residue	516	516	.	.	.	Note=Phosphoserine%3B by PDPK1 and TTBK1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16923168,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:9614189;Dbxref=PMID:15546861,PMID:16923168,PMID:19451179,PMID:9614189	
P10636	UniProtKB	Modified residue	519	519	.	.	.	Note=Phosphoserine%3B by CK1%2C PDPK1 and TTBK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:14761950,ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16923168,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:21327254,ECO:0000269|PubMed:9614189;Dbxref=PMID:18220336,PMID:23186163,PMID:24275569,PMID:14761950,PMID:15546861,PMID:16923168,PMID:19451179,PMID:21327254,PMID:9614189	
P10636	UniProtKB	Modified residue	522	522	.	.	.	Note=Phosphothreonine%3B by CK1 and PDPK1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14761950,ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:19451179;Dbxref=PMID:14761950,PMID:15546861,PMID:19451179	
P10636	UniProtKB	Modified residue	529	529	.	.	.	Note=Phosphothreonine%3B by BRSK1%2C BRSK2%2C DYRK2 and PDPK1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:18599021,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:21985311,ECO:0000269|PubMed:9614189;Dbxref=PMID:15546861,PMID:18599021,PMID:19451179,PMID:21985311,PMID:9614189	
P10636	UniProtKB	Modified residue	531	531	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16443603,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:9614189;Dbxref=PMID:15546861,PMID:16443603,PMID:19451179,PMID:9614189	
P10636	UniProtKB	Modified residue	534	534	.	.	.	Note=Phosphothreonine%3B by PDPK1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16443603,ECO:0000269|PubMed:19451179;Dbxref=PMID:16443603,PMID:19451179	
P10636	UniProtKB	Modified residue	542	542	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	548	548	.	.	.	Note=Phosphothreonine%3B by GSK3-beta and PDPK1;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:14690523,ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16443603;Dbxref=PMID:23186163,PMID:14690523,PMID:15546861,PMID:16443603	
P10636	UniProtKB	Modified residue	552	552	.	.	.	Note=Phosphoserine%3B by PDPK1;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16443603,ECO:0000269|PubMed:9614189;Dbxref=PMID:23186163,PMID:15546861,PMID:16443603,PMID:9614189	
P10636	UniProtKB	Modified residue	554	554	.	.	.	Note=Phosphoserine%3B by PHK;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16443603,ECO:0000269|PubMed:8999860;Dbxref=PMID:16443603,PMID:8999860	
P10636	UniProtKB	Modified residue	576	576	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	576	576	.	.	.	Note=N6-methyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	579	579	.	.	.	Note=Phosphoserine%3B by MARK1%2C MARK2%2C MARK3%2C MARK4%2C BRSK1%2C BRSK2 and PHK;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16443603,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:21985311,ECO:0000269|PubMed:23666762,ECO:0000269|PubMed:7706316,ECO:0000269|PubMed:8999860,ECO:0000269|PubMed:9614189;Dbxref=PMID:15546861,PMID:16443603,PMID:19451179,PMID:21985311,PMID:23666762,PMID:7706316,PMID:8999860,PMID:9614189	
P10636	UniProtKB	Modified residue	596	596	.	.	.	Note=Deamidated asparagine%3B in tau and PHF-tau%3B partial;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1512244;Dbxref=PMID:1512244	
P10636	UniProtKB	Modified residue	598	598	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	602	602	.	.	.	Note=Phosphoserine%3B by PHK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8999860;Dbxref=PMID:8999860	
P10636	UniProtKB	Modified residue	607	607	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	610	610	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Modified residue	615	615	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	622	622	.	.	.	Note=Phosphoserine%3B by PHK;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7706316,ECO:0000269|PubMed:8999860;Dbxref=PMID:7706316,PMID:8999860	
P10636	UniProtKB	Modified residue	628	628	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	628	628	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	634	634	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	638	638	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	641	641	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Modified residue	648	648	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	660	660	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	664	664	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	666	666	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	669	669	.	.	.	Note=Phosphoserine%3B by PHK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8999860;Dbxref=PMID:8999860	
P10636	UniProtKB	Modified residue	673	673	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7706316;Dbxref=PMID:7706316	
P10636	UniProtKB	Modified residue	686	686	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	702	702	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	711	711	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	713	713	.	.	.	Note=Phosphoserine%3B by CK1 and PDPK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:14761950,ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16443603,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:21327254,ECO:0000269|PubMed:9614189;Dbxref=PMID:19690332,PMID:23186163,PMID:14761950,PMID:15546861,PMID:16443603,PMID:19451179,PMID:21327254,PMID:9614189	
P10636	UniProtKB	Modified residue	717	717	.	.	.	Note=Phosphoserine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
P10636	UniProtKB	Modified residue	720	720	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Modified residue	721	721	.	.	.	Note=Phosphoserine%3B by CK1 and PDPK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:14761950,ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:21327254,ECO:0000269|PubMed:9614189;Dbxref=PMID:19690332,PMID:23186163,PMID:14761950,PMID:15546861,PMID:19451179,PMID:21327254,PMID:9614189	
P10636	UniProtKB	Modified residue	726	726	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19690332,ECO:0000269|PubMed:15546861;Dbxref=PMID:19690332,PMID:15546861	
P10636	UniProtKB	Modified residue	733	733	.	.	.	Note=Phosphoserine%3B by CaMK2 and TTBK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16923168;Dbxref=PMID:16923168	
P10636	UniProtKB	Modified residue	739	739	.	.	.	Note=Phosphoserine%3B by PDPK1 and TTBK1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16443603,ECO:0000269|PubMed:16923168,ECO:0000269|PubMed:19451179,ECO:0000269|PubMed:9614189;Dbxref=PMID:16443603,PMID:16923168,PMID:19451179,PMID:9614189	
P10636	UniProtKB	Modified residue	744	744	.	.	.	Note=Phosphothreonine%3B by TTBK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16923168;Dbxref=PMID:16923168	
P10636	UniProtKB	Glycosylation	87	87	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	383	383	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	467	467	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	480	480	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	491	491	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	525	525	.	.	.	Note=O-linked (GlcNAc) serine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21327254;Dbxref=PMID:21327254	
P10636	UniProtKB	Glycosylation	542	542	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	551	551	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	555	555	.	.	.	Note=O-linked (GlcNAc) serine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21327254;Dbxref=PMID:21327254	
P10636	UniProtKB	Glycosylation	576	576	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	597	597	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	598	598	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	664	664	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	670	670	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	686	686	.	.	.	Note=N-linked (Glc) (glycation) lysine%3B in PHF-tau%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9326300;Dbxref=PMID:9326300	
P10636	UniProtKB	Glycosylation	717	717	.	.	.	Note=O-linked (GlcNAc) serine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21327254;Dbxref=PMID:21327254	
P10636	UniProtKB	Disulfide bond	608	639	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
P10636	UniProtKB	Cross-link	44	44	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	571	571	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B in PHF-tau;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16443603;Dbxref=PMID:16443603	
P10636	UniProtKB	Cross-link	576	576	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	584	584	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	598	598	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	615	615	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	628	628	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B in PHF-tau;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16443603;Dbxref=PMID:16443603	
P10636	UniProtKB	Cross-link	634	634	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	638	638	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	648	648	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	660	660	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	664	664	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	670	670	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B in PHF-tau;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16443603;Dbxref=PMID:16443603	
P10636	UniProtKB	Cross-link	686	686	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	692	692	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Cross-link	702	702	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P10637	
P10636	UniProtKB	Alternative sequence	1	44	.	.	.	ID=VSP_003175;Note=In isoform Tau-A. MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLK->MLRALQQRKR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:2516729;Dbxref=PMID:2516729	
P10636	UniProtKB	Alternative sequence	45	73	.	.	.	ID=VSP_003176;Note=In isoform Tau-A%2C isoform Tau-D and isoform Fetal-tau. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:2498079,ECO:0000303|PubMed:2516729,ECO:0000303|PubMed:3131773,ECO:0000303|Ref.7;Dbxref=PMID:15489334,PMID:2498079,PMID:2516729,PMID:3131773	
P10636	UniProtKB	Alternative sequence	74	102	.	.	.	ID=VSP_003177;Note=In isoform Tau-A%2C isoform Tau-B%2C isoform Tau-D%2C isoform Tau-E and isoform Fetal-tau. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:2484340,ECO:0000303|PubMed:2498079,ECO:0000303|PubMed:2516729,ECO:0000303|PubMed:3131773,ECO:0000303|Ref.6,ECO:0000303|Ref.7;Dbxref=PMID:15489334,PMID:2484340,PMID:2498079,PMID:2516729,PMID:3131773	
P10636	UniProtKB	Alternative sequence	103	104	.	.	.	ID=VSP_003178;Note=In isoform Tau-A. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:2516729;Dbxref=PMID:2516729	
P10636	UniProtKB	Alternative sequence	125	375	.	.	.	ID=VSP_003179;Note=In isoform Tau-A%2C isoform Tau-B%2C isoform Tau-C%2C isoform Tau-D%2C isoform Tau-E%2C isoform Tau-F and isoform Fetal-tau. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:2484340,ECO:0000303|PubMed:2498079,ECO:0000303|PubMed:2516729,ECO:0000303|PubMed:3131773,ECO:0000303|Ref.6,ECO:0000303|Ref.7;Dbxref=PMID:15489334,PMID:2484340,PMID:2498079,PMID:2516729,PMID:3131773	
P10636	UniProtKB	Alternative sequence	395	460	.	.	.	ID=VSP_003180;Note=In isoform Tau-A%2C isoform Tau-B%2C isoform Tau-C%2C isoform Tau-D%2C isoform Tau-E%2C isoform Tau-F and isoform Fetal-tau. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:2484340,ECO:0000303|PubMed:2498079,ECO:0000303|PubMed:2516729,ECO:0000303|PubMed:3131773,ECO:0000303|Ref.6,ECO:0000303|Ref.7;Dbxref=PMID:15489334,PMID:2484340,PMID:2498079,PMID:2516729,PMID:3131773	
P10636	UniProtKB	Alternative sequence	502	502	.	.	.	ID=VSP_026780;Note=In isoform Tau-G. S->SATKQVQRRPPPAGPRSER;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P10636	UniProtKB	Alternative sequence	592	622	.	.	.	ID=VSP_003181;Note=In isoform Tau-A%2C isoform Tau-B%2C isoform Tau-C and isoform Fetal-tau. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:2484340,ECO:0000303|PubMed:2516729,ECO:0000303|PubMed:3131773,ECO:0000303|Ref.7;Dbxref=PMID:15489334,PMID:2484340,PMID:2516729,PMID:3131773	
P10636	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_019660;Note=In FTD%3B reduces the ability of tau to promote microtubule assembly and promotes fibril formation in vitro. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11921059;Dbxref=dbSNP:rs63750959,PMID:11921059	
P10636	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_019661;Note=In PSNP1%3B delays assembly initiation and lowers the mass of microtubules formed%3B but the assembly rate is increased compared to normal tau. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12325083;Dbxref=dbSNP:rs63750959,PMID:12325083	
P10636	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_064622;Note=T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20020531;Dbxref=dbSNP:rs144611688,PMID:20020531	
P10636	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_064623;Note=T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20020531;Dbxref=dbSNP:rs748728879,PMID:20020531	
P10636	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_010340;Note=Risk factor for PSNP1. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10534245,ECO:0000269|PubMed:9629852;Dbxref=dbSNP:rs62063786,PMID:10534245,PMID:9629852	
P10636	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_010341;Note=Risk factor for PSNP1. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10534245,ECO:0000269|PubMed:9629852;Dbxref=dbSNP:rs62063787,PMID:10534245,PMID:9629852	
P10636	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_056121;Note=R->W;Dbxref=dbSNP:rs17651549	
P10636	UniProtKB	Natural variant	441	441	.	.	.	ID=VAR_010342;Note=Y->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1420178,ECO:0000269|PubMed:15365985,ECO:0000269|PubMed:9629852;Dbxref=dbSNP:rs2258689,PMID:1420178,PMID:15365985,PMID:9629852	
P10636	UniProtKB	Natural variant	447	447	.	.	.	ID=VAR_010343;Note=S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9629852;Dbxref=dbSNP:rs10445337,PMID:9629852	
P10636	UniProtKB	Natural variant	574	574	.	.	.	ID=VAR_010344;Note=In PIDB%3B reduces the ability to promote microtubule assembly by 70%25. K->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11089577,ECO:0000269|PubMed:11117542;Dbxref=dbSNP:rs63750129,PMID:11089577,PMID:11117542	
P10636	UniProtKB	Natural variant	583	583	.	.	.	ID=VAR_019662;Note=In FTD%3B less able to promote microtubule assembly than wild-type tau. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12509859;Dbxref=dbSNP:rs63750349,PMID:12509859	
P10636	UniProtKB	Natural variant	589	589	.	.	.	ID=VAR_010345;Note=In FTD. G->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9641683,ECO:0000269|PubMed:9973279;Dbxref=dbSNP:rs63750376,PMID:9641683,PMID:9973279	
P10636	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_010346;Note=In FTD%3B with parkinsonism. N->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10412802,ECO:0000269|PubMed:10489057,ECO:0000269|PubMed:10802785,ECO:0000269|PubMed:12473774,ECO:0000269|PubMed:9789048;Dbxref=dbSNP:rs63750756,PMID:10412802,PMID:10489057,PMID:10802785,PMID:12473774,PMID:9789048	
P10636	UniProtKB	Natural variant	597	597	.	.	.	ID=VAR_010347;Note=In FTD. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9973279;Dbxref=PMID:9973279	
P10636	UniProtKB	Natural variant	613	613	.	.	.	ID=VAR_019663;Note=In FTD%3B reduced the ability of tau to promote microtubule assembly without having a significant effect on tau filament formation%3B effects at both the RNA and the protein level. N->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11585254,ECO:0000269|PubMed:11906000;Dbxref=dbSNP:rs63750416,PMID:11585254,PMID:11906000	
P10636	UniProtKB	Natural variant	613	613	.	.	.	ID=VAR_019664;Note=In PSNP1/atypical PSNP1%3B heterozygosity may be a risk factor for both a PSNP1-like syndrome and Parkinson disease%3B reduced the ability of tau to promote microtubule assembly without having a significant effect on tau filament formation%3B effects at both the RNA and the protein level. Missing;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11220749,ECO:0000269|PubMed:11906000,ECO:0000269|PubMed:14991828,ECO:0000269|PubMed:14991829;Dbxref=PMID:11220749,PMID:11906000,PMID:14991828,PMID:14991829	
P10636	UniProtKB	Natural variant	617	617	.	.	.	ID=VAR_064624;Note=V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20020531;Dbxref=dbSNP:rs116733906,PMID:20020531	
P10636	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_010348;Note=In FTD%3B most common mutation%3B reduction in the ability to promote microtubule assembly%3B accelerates aggregation of tau into filaments. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10214944,ECO:0000269|PubMed:9641683,ECO:0000269|PubMed:9736786,ECO:0000269|PubMed:9789048,ECO:0000269|PubMed:9973279;Dbxref=dbSNP:rs63751273,PMID:10214944,PMID:9641683,PMID:9736786,PMID:9789048,PMID:9973279	
P10636	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_010349;Note=In FTD and CBD%3B reduction in the ability to promote microtubule assembly. P->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10374757,ECO:0000269|PubMed:10553987,ECO:0000269|PubMed:11071507,ECO:0000269|PubMed:16240366;Dbxref=dbSNP:rs63751438,PMID:10374757,PMID:10553987,PMID:11071507,PMID:16240366	
P10636	UniProtKB	Natural variant	620	620	.	.	.	ID=VAR_037439;Note=In PSNP1. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16157753;Dbxref=dbSNP:rs63751391,PMID:16157753	
P10636	UniProtKB	Natural variant	622	622	.	.	.	ID=VAR_010350;Note=In FTD%3B minimal parkinsonism%3B very early age of onset. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10208578;Dbxref=dbSNP:rs63751165,PMID:10208578	
P10636	UniProtKB	Natural variant	634	634	.	.	.	ID=VAR_037440;Note=In FTD. K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15883319;Dbxref=dbSNP:rs63750092,PMID:15883319	
P10636	UniProtKB	Natural variant	637	637	.	.	.	ID=VAR_019665;Note=In PIDB%3B markedly reduced ability of tau to promote microtubule assembly. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11891833;Dbxref=dbSNP:rs63750635,PMID:11891833	
P10636	UniProtKB	Natural variant	654	654	.	.	.	ID=VAR_010351;Note=In FTD%3B ultrastructural and biochemical characteristics indistinguishable from Alzheimer disease%3B accelerates aggregation of tau into filaments. V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10214944,ECO:0000269|PubMed:9629852;Dbxref=dbSNP:rs63750570,PMID:10214944,PMID:9629852	
P10636	UniProtKB	Natural variant	659	659	.	.	.	ID=VAR_019666;Note=In FTD. E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11117541;Dbxref=dbSNP:rs63750711,PMID:11117541	
P10636	UniProtKB	Natural variant	669	669	.	.	.	ID=VAR_019667;Note=In fatal respiratory hypoventilation%3B unusual apparent autosomal recessive inheritance%3B reduced binding to microtubules as well as increased fibrillization and aggregation. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14595660;Dbxref=dbSNP:rs63750425,PMID:14595660	
P10636	UniProtKB	Natural variant	686	686	.	.	.	ID=VAR_019668;Note=In PIDB%3B 90%25 reduction in the rate of microtubule assembly. K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11601501;Dbxref=dbSNP:rs63751264,PMID:11601501	
P10636	UniProtKB	Natural variant	706	706	.	.	.	ID=VAR_010352;Note=In PIDB%3B in vitro the mutation reduces the ability of tau to promote microtubule assembly by 25 to 30%25. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10604746,ECO:0000269|PubMed:11117542;Dbxref=dbSNP:rs63750512,PMID:10604746,PMID:11117542	
P10636	UniProtKB	Natural variant	723	723	.	.	.	ID=VAR_010353;Note=In FTD/Alzheimer disease%3B accelerates aggregation of tau into filaments%3B reduces tau phosphorylation in cells compared to both the wild-type and other mutant forms. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10214944,ECO:0000269|PubMed:11278002,ECO:0000269|PubMed:11889249,ECO:0000269|PubMed:14517953,ECO:0000269|PubMed:26086902,ECO:0000269|PubMed:9641683,ECO:0000269|PubMed:9973279;Dbxref=dbSNP:rs63750424,PMID:10214944,PMID:11278002,PMID:11889249,PMID:14517953,PMID:26086902,PMID:9641683,PMID:9973279	
P10636	UniProtKB	Mutagenesis	515	515	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	516	516	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	519	519	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	531	531	.	.	.	Note=No decrease in microtubule-binding and nucleation activity after in vitro phosphorylation of mutant protein. S->A	
P10636	UniProtKB	Mutagenesis	548	548	.	.	.	Note=50%25 Decrease in microtubule-binding after in vitro phosphorylation of mutant protein. T->A	
P10636	UniProtKB	Mutagenesis	548	548	.	.	.	Note=No association with plasma membrane. T->E	
P10636	UniProtKB	Mutagenesis	552	552	.	.	.	Note=70%25 decrease in microtubule-binding after in vitro phosphorylation of mutant protein. S->A	
P10636	UniProtKB	Mutagenesis	552	552	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	579	579	.	.	.	Note=8%25 decrease in microtubule-binding after in vitro phosphorylation of mutant protein. S->A	
P10636	UniProtKB	Mutagenesis	713	713	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	721	721	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	726	726	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	730	730	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Mutagenesis	739	739	.	.	.	Note=No association with plasma membrane. S->E	
P10636	UniProtKB	Sequence conflict	48	48	.	.	.	Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P10636	UniProtKB	Sequence conflict	414	414	.	.	.	Note=H->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P10636	UniProtKB	Sequence conflict	557	557	.	.	.	Note=K->M;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P10636	UniProtKB	Sequence conflict	591	591	.	.	.	Note=K->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P10636	UniProtKB	Sequence conflict	617	617	.	.	.	Note=V->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P10636	UniProtKB	Sequence conflict	622	622	.	.	.	Note=S->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P10636	UniProtKB	Helix	60	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ZV3	
P10636	UniProtKB	Turn	63	65	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ZV3	
P10636	UniProtKB	Turn	579	582	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6CVJ	
P10636	UniProtKB	Beta strand	587	590	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5N5A	
P10636	UniProtKB	Helix	596	599	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2MZ7	
P10636	UniProtKB	Beta strand	603	609	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Beta strand	611	617	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Beta strand	618	620	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MP5	
P10636	UniProtKB	Turn	622	624	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5N5B	
P10636	UniProtKB	Beta strand	625	627	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4E0N	
P10636	UniProtKB	Beta strand	635	642	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Beta strand	645	647	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Beta strand	653	672	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Beta strand	676	679	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Beta strand	682	684	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Beta strand	686	694	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GX5	
P10636	UniProtKB	Helix	739	741	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6H06	
